RE: Sky news10 Jun 2023 14:55
H2 is critical.
UNIVERSAL seems to be BP (specifically Jennson and AZ) testing the market for the product.
The mini-trials are designed to identify the patients that will benefit most in order for a P3 to succeed this time.
So patience. Nothing else will increase the share price but a P3.
Regardess, I will sell this when it reaches above 20p now. This has become a tiresome. This is still an AIM pharmaceutical stock that has never had a commercialised product in 20 years of existence, it is still a binary outcome, and the salaries of the BoD are starting to look like middle-aged men coinining it in while they still can because they'll never find similar jobs at their age.
If a P3 does occur, then, obviously, the sp will rise above 20p.